Early asthma prophylaxis, natural history, skeletal development and economy (EASE): A pilot randomised controlled trial

Health Technology Assessment

Volumn 4, Issue 28, 2000, Pages

  Baxter Jones, A D G ^a   Helms, P J ^a   Russell, G ^a   Grant, A ^a   Ross, S ^a   Cairns, J A ^a   Ritchie, L ^a   Taylor, R ^a   Reid, D M ^a   Osman, L M ^a   Robins, S ^a   Fletcher, M E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE;

AIRWAY OBSTRUCTION; ASTHMA; CHILD CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; HEALTH CARE COST; HUMAN; LUNG FUNCTION; METABOLIC BONE DISEASE; METERED DOSE INHALER; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PILOT STUDY; PROPHYLAXIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOM;

EID: 0033645170     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta4280     Document Type: Review

References (118)

1. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14 year old children across Great Britain (International Study of Asthma and Allergies in Childhood, ISAAC, UK)
2. Respiratory symptoms and atopy in Aberdeen schoolchildren: Evidence from two surveys 25 years apart
3. Changes in asthma prevalence: Two surveys 15 years apart
4. Changing prevalence of asthma in school children: Evidence for diagnostic changes in asthma in two surveys 13 yrs apart
5. Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren
6. Prevalence of asthma and wheeze in the highlands of Scotland
7. Asthma - time for a change of name?
8. Wheezy bronchitis revisited
9. Out of the mouths of babes and sucklings: Lessons from early childhood asthma
10. Asthma and wheezing in the first six years of life
11. Outcome of wheeze in childhood: Symptoms and pulmonary function 25 years later
12. Associations between respiratory symptoms, bronchial response to methacholine, and atopy in two age groups of schoolchildren
13. Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma
14. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children
15. Wheezing infants
16. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants
17. Natural history of asthma in childhood - A birth cohort study
18. The natural history of respiratory symptoms in preschool children
19. Asthma - The role of new drugs
20. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
21. Inhaled steroids and the risk of hospitalization for asthma
22. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in the prevalence of asthma
23. Accuracy of asthma treatment in schoolchildren in NSW, Australia
24. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: Randomised double blind placebo controlled trial
25. The British Guidelines on Asthma Management 1995 review and position statement
26. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
27. Asthma, inhaled corticosteroid treatment, and growth
28. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids
29. Inhaled glucocorticoid therapy in children: How much is safe?
30. Asthma: Addressing parents' fears and concerns
31. High-dose inhaled steroids in asthmatic children
32. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate
33. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids
34. Intergrated plasma cortisol concentration in children with asthma receiving longterm inhaled corticosteroids
35. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma
36. Short-term measurement of linear growth in preterm infants: Validation of a hand-held knemometer
37. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone diproprionate
38. Growth of asthmatic children
39. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children
40. Childhood asthma and growth - A review of the literature
41. Assessment of bone status using the contact ultrasound bone analyser
42. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases
43. Pyridinium crosslink as markers of bone resorption
44. Osteocalcin, growth, and inhaled corticosteroids: A prospective study
45. Conceptual and methodologic issues in quantifying perceptual accuracy in childhood asthma
46. Measuring quality of life in asthma
47. Quality-of-life considerations in the treatment of asthma
48. Measuring quality of life in children with asthma
49. Quality of life in childhood asthma: Development of the Childhood Asthma Questionnaires
50. The reproducibility of the Childhood Asthma Questionnaires: Measures of quality of life for children with asthma aged 4-16 years
51. Pediatrics: Assessing quality of life
52. Quality-of-life factors for parents of children with asthma
53. Measuring quality of life for young children with asthma and their families
54. Measuring quality of life in the parents of children with asthma
55. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents
56. Symptoms, quality of life and health service contact among young adults with mild asthma
57. Association between health-related quality of life and consultation for respiratory symptoms: Results from the DIMCA programme
58. The health economics of treating mild asthma
59. Social effects of wheeze in childhood: A 25 year follow up
60. Treating asthma: Health economic aspects
61. The burden of paediatric asthma
62. Pragmatic versus explanatory trials
63. What are pragmatic trials?
64. The pragmatic approach to stroke trial design: Stroke register, pilot trial, assessment of neurological then functional outcome
65. Questioning behaviour in general practice: A pragmatic study
66. Is bleeding time measurement useful for choosing the liver biopsy route? The results of a pragmatic, prospective multicentric study in 219 patients
67. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial
68. Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care
69. Open access follow up for inflammatory bowel disease: Pragmatic randomised trial and cost effectiveness study
70. Endocrine and lung function in asthmatic children on inhaled steroids
71. Gender- and race-specific effects of asthma and wheeze on level and growth of lung function in children in six U.S. cities
72. How large a sample
73. Dynamic lung volumes and forced ventilatory flow rates
74. Validation of respiratory inductance plethysmography (Respitrace) for the measurement of tidal breathing parameters in newborns
75. Evaluation of a tidal expiratory flow index in healthy and diseased infants
76. Analysis of tidal breathing parameters in infancy: How variable is TPTEF:TE?
77. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma
78. Are tidal breathing indices useful in infant bronchial challenge tests?
79. Infant respiratory function after RSV-proven bronchiolitis
80. Tidal breathing analysis as a measure of airway obstruction in children three years of age and older
81. Pneumotachographic nitrogen washout method for measurement of the volume of trapped gas in the lungs
82. Prediction of mechanical properties of the human calcaneus by broadband ultrasonic attenuation
83. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography
84. Assessment of the child with asthma
85. Home recording of peak expiratory flow rates and perception of asthma
86. Night cough counts and diary card scores in asthma
87. Poor agreement between reported and recorded nocturnal cough in asthma
88. Epidemiologic approaches for the identification of asthma
89. Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children
90. Diurnal variation in bronchial responsiveness in asthmatic children
91. Measurement of health status. Ascertaining the minimal clinically important difference
92. International study of asthma and allergies in childhood (ISAAC): Rationale and methods
93. Grommets, tonsillectomies, and deprivation in Scotland
94. Social deprivation and tooth decay in Scottish schoolchildren
95. Perinatal mortality in an English health region: Geographical distribution and association with socio-economic factors
96. Determining a minimal important change in a disease-specific quality of life questionnaire
97. Physician-diagnosed asthma and drug utilization in the European community respiratory health survey
98. One-year follow-up of young children hospitalized for wheezing: The influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma
99. Bone turnover in malnourished children
100. Effects of 22 months of treatment with inhaled corticosteroids and / or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma
101. Tidal breathing in young children: Comparison of measurement by respiratory inductance plethysmography to a facemask pneumotachograph system
102. Signal processing of thoraco-abdominal movement in infants
103. A signal processing technique to determine respiratory function parameters in infants using inductive plethysmography
104. Measurement of airway resistance using the interrupter technique in preschool children in the ambulatory setting
105. Changes in bone markers in children with asthma during inhaled budesonide and nedocromile treatments
106. Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma
107. Bone density in asthmatic patients taking high dose inhaled beclomethasone diproprionate and intermittent systemic corticosteroids
108. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide
109. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
110. Metered-dose inhaler adherence in a clinical trial
111. An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone
112. Measuring compliance with inhaled medication in asthma
113. Lung function in white children aged 4 to 19 years: I - Spirometry